The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Oct. 12, 2021
Applicants:

Terry Earl Brady, The Valley, AL;

Anthony Lee Dellinger, Brown Summit, NC (US);

Melinda K. M. Goddard, The Valley, AL;

Kristen Dellinger, Brown Summit, NC (US);

Inventors:

Terry Earl Brady, The Valley, AL;

Anthony Lee Dellinger, Brown Summit, NC (US);

Melinda K. M. Goddard, The Valley, AL;

Kristen Dellinger, Brown Summit, NC (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/44 (2006.01); A61K 31/11 (2006.01); A61K 9/02 (2006.01); A61K 38/17 (2006.01); A61K 31/57 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 33/44 (2013.01); A61K 9/0034 (2013.01); A61K 9/02 (2013.01); A61K 31/11 (2013.01); A61K 31/57 (2013.01); A61K 38/1703 (2013.01);
Abstract

The present invention provides the methods and composition useful as a contraceptive by preventing motile sperm from reaching a mature ovum, thereby blocking fertilization and preventing pregnancy. The contraceptive is comprised of halogen functionalized fullerene nanoparticles (halo fullerenes) and chemotactic stimulants that act synergistically to divert, incapacitate and ultimately rupture spermatozoa to avert fertilization. When applied vaginally prior to coitus, the suspension is activated by exposure to spermatozoa upon insemination. Notably, non-spermatozoa cells are unaffected by the pH-neutral suspension; however, closer to the same scale, microbes are susceptible to its inherent biocidal properties. Following application and coitus, the contraceptive evacuates naturally, along with seminal and vaginal fluids thereafter.


Find Patent Forward Citations

Loading…